Author:
Escobar Miguel A.,Nguyen Trinh,Montanez Natalie A.
Publisher
Springer International Publishing
Reference38 articles.
1. Murphy MC, Klein HG. Blood component and pharmacologic therapy for hemostatic disorders. In: Kitchens C, et al., editors. Consultative hemostasis and thrombosis. 4th ed. Philadelphia: Elsevier; 2019.
2. Samuelson Bannow BT, Konkle BA. Von Willebrand disease. In: Kitchens C, et al., editors. Consultative hemostasis and thrombosis. 4th ed. Philadelphia: Elsevier; 2019.
3. Nichols WL, Hultin MB, James AH, Manco-Johnson MJ, Montgomery RR, Ortel TL, Rick ME, Sadler JE, Weinstein M, Yawn BP. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) expert panel report (USA). Haemophilia. 2008;14(2):171–232. https://doi.org/10.1111/j.1365-2516.2007.01643.x.
4. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Treatment guidelines working group on behalf of the world federation of hemophilia. Guidelines for the management of hemophilia. Haemophilia. 2013;19(1):e1–47. https://doi.org/10.1111/j.1365-2516.2012.02909.x. Epub 2012 July 6.
5. VONVENDI [package insert]. Lexington, MA: Baxalta US Inc; 2018.